1 Tirzepatide 15 mg: -11.2 kg average weight loss Injectable semaglutide 1 mg: -5.7 kg average weight loss HbA1c: -2.30% with tirzepatide 15 mg vs -1.86% with semaglutide 1 mg Rybelsus 14 mg (the highest available oral dose) produces roughly equivalent blood levels to injectable semaglutide 0.5-1.0 mg per week, which is at or below the injectable dose tested in SURPASS-2
Intramuscular (IM) injection, by contrast, delivers medication directly into muscle tissue, which has a different vascular supply and absorption profile
Even though each drug has different FDA-approved usages, they are all often used off-label for blood sugar management and weight reduction, regardless of whether thats the individual drugs FDA-approved use case
Tirzepatide common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, and upset stomach
To minimize the risk and intensity of gastrointestinal side effects, it is recommended to start with a low dose of semaglutide and gradually increase the dosage
